Summary
At the All-In Summit 2025, Mark Cuban explains how Cost Plus Drugs exposes opaque PBM and insurer pricing, argues both political parties have failed to sell obvious fixes such as the expiring ACA credits, and calls tariffs a hidden tax on small businesses. Tucker Carlson joins to debate populism, immigration and housing, warns that economic frustration will drive a populist backlash, and says dollar devaluation pushes him toward physical stores of value, while Cuban cites a large Bitcoin position held for years as a hedge. The session closes with AI job displacement, Cuban's view that robotics rather than LLMs is the long-term AI story, and a lightning round on Epstein, Putin, SSRIs, Western demographic decline and Israel.
- Cuban: PBMs and vertically integrated insurers run an opaque pricing system; Cost Plus Drugs publishes cost plus a 15% markup, and manufacturers fear PBM formulary retaliation more than the MFN executive order.
- Cuban is launching Cost Plus Wellness with published cash-pay contracts across 8,000 providers.
- Cuban says both parties are failing; expiring enhanced ACA credits will sharply raise premiums for 12.5 million people.
- Cuban: 10-20% effective tariffs and related friction are pushing small businesses out of business while headline investment pledges get the attention.
- Tucker: unaffordable housing and economic frustration make a Mamdani-style economic-populist wave likely; immigration-driven population change is the core Western issue.
- On deficits, Tucker cites dollar devaluation and a preference for physical assets such as land and gold; Cuban says he has held a large Bitcoin position for about five years as a hedge.
- Cuban on AI: big companies automate first, small and mid-size firms need AI natives, and the long-term impact is robotics processing video rather than text LLMs.
- Lightning round: Epstein, Putin and the definition of a war crime, calls to ban SSRIs and stimulants, Canada's MAID program, the Charlotte stabbing, antisemitism and criticism of Israel's government.